Catalyst Wire Dossier Catalyst Wire Dossier

Ertugliflozin

ertugliflozin · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

28 regulatory and trial events tracked for Ertugliflozin, covering 2016-02-17 to 2026-06-04. Get the full timeline:

Most recent: Clinical Trial Results: Ertugliflozin: Cardioprotective Effects on Epicardial Fat [EARLY_Phase 1]

See pricing